Hannah Jones credits paid medical leave with helping her survive an aggressive form of breast cancer. Her employer provided time off for chemotherapy...

Hannah Jones credits paid medical leave with helping her survive an aggressive form of breast cancer. Her employer provided time off for chemotherapy...

Hannah Jones credits paid medical leave with helping her survive an aggressive form of breast cancer. Her employer provided time off for chemotherapy...

Hannah Jones credits paid medical leave with helping her survive an aggressive form of breast cancer. Her employer provided time off for chemotherapy...

Researchers in Australia are developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer (TNBC) --...

Researchers in Australia are developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer (TNBC) --...

Delays in cancer treatments can be the difference between life and death, and chief executive officer of Helping Our Patients Everywhere (HOPE),...

A dendritic cell vaccine boosts immune response and treatment outcomes for HER2-positive breast cancer.

A dendritic cell vaccine boosts immune response and treatment outcomes for HER2-positive breast cancer.

University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggressive form of breast cancer.